CTI BIOPHARMA CORP Annual Costs and Expenses in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Cti Biopharma Corp quarterly/annual Costs and Expenses history and growth rate from 2010 to 2022.
  • Cti Biopharma Corp Costs and Expenses for the quarter ending March 31, 2023 was $33.3M, a 10.8% decline year-over-year.
  • Cti Biopharma Corp Costs and Expenses for the twelve months ending March 31, 2023 was $130M, a 12.1% increase year-over-year.
  • Cti Biopharma Corp annual Costs and Expenses for 2022 was $134M, a 40.3% increase from 2021.
  • Cti Biopharma Corp annual Costs and Expenses for 2021 was $95.3M, a 99.6% increase from 2020.
  • Cti Biopharma Corp annual Costs and Expenses for 2020 was $47.8M, a 8.43% increase from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $134M +$38.4M +40.3% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-06
2021 $95.3M +$47.6M +99.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-06
2020 $47.8M +$3.71M +8.43% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $44.1M -$15.1M -25.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-17
2018 $59.2M -$5.48M -8.47% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 $64.7M -$41.9M -39.3% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-13
2016 $107M -$26.2M -19.7% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-07
2015 $133M -$13.5M -9.25% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2014 $146M +$70.1M +92% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-02
2013 $76.2M -$25.3M -24.9% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-17
2012 $101M +$39.3M +63.2% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 $62.2M -$16.5M -21% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-04
2010 $78.7M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.